The detection of sonographic markers can modify the risk of fetal Down syndrome (DS) and is the basis of the so-called genetic sonogram.
INTRODUCTION
Nyberg et al 1 have stated that the presence or absence of sonographic markers can substantially modify the risk of fetal Down syndrome (DS) and is the basis of the so-called genetic sonogram. Fetuses that have structural anomalies often have chromosomal abnormalities. Between 10 and 37% of fetuses with structural anomalies also have chromosomal defects. Half of these have trisomies, a quarter monosomy, 10 to 15% a mosaic and a few triploidy and miscellaneous aneuploidies.
2,3
Nicolaides et al 4 have shown that fetuses that have more than one anomaly are more likely to have chromosomal anomalies. With one anomaly, the risk of chromosomal abnormality is 2%, it rises to 11% with two anomalies, to 66% with five and up to 92% with eight anomalies. Krantz et al 5 have evaluated both the genetic sonogram as well as biochemical screening. First trimester combined screening alone resulted in a detection rate of 88.5% with a 4.2% falsepositive rate. The genetic sonogram included nuchal fold, hyperechogenic bowel, short femur and humerus, echogenic intracardiac foci (ECF), pyelectasis and major abnormality. The sonographic examination (with one marker found) detected an additional 8% of DS with false-positive rate of 13.2%. The overall detection rate was 94.6% and falsepositive rate of 5.4%. They concluded that second trimester genetic sonogram, if used properly, can be an effective sequential screening following first trimester DS biochemical screening.
In another study, detecting chromosomal abnormalities by second-trimester genetic sonogram in a community-based antenatal testing unit, Bottalico et al 6 
Trisomy 21-Case Reports and Literature Review
In this review, I describe herein trisomy 21 cases, detected in early anomaly scan, with a review of the literature regarding the abnormalities found in these cases. The next five cases share a common pathology, Down syndrome, but each one has a different sonographic appearance. The first case, age 36 years, in her 14+5 weeks of gestation, presented with the following findings-increased nuchal fold (4.3 mm), absent one nasal bone and hypoplastic middle phalanx of the fifth digit (MPFD). Nuchal translucency (NT) is the sonographic appearance of a collection of fluid under the skin behind the fetal neck in the first-trimester of pregnancy. It is a sonographic examination done between 11-13+6 weeks of gestation with the 12 week as the preferred time. In fetuses carrying chromosomal abnormalities, cardiac defects and many genetic syndromes, the amount of fluid is larger and hence, the NT thickness is increased. Nicolaides et al 9 have
examined the significance of fetal NT at 10 to 14 weeks' gestation in the prediction of abnormal fetal karyotype. The incidence of chromosomal defects was 3%. In the 6% fetuses with NT 3 to 8 mm thick the incidence of chromosomal defects was 35%. In contrast, only 1% of the remaining fetuses were chromosomally abnormal. In Pandya et al's study, 10 the NT was above the 95th percentile in 77% of fetuses with trisomy 21 and in 78% of those with other chromosomal defects. They proposed, on the basis of the distribution of NT measurements in normal fetuses and those with trisomy 21, a new method of screening which involves assessment of individual risk based on the combination of fetal NT, crown-rump length and maternal age. We should remember, as in Kagan's study, 11 17 What is the normal sequence of ossification process of the MPFD? Radiographic post mortem studies show that the MPFD develops last of all the phalanx in the hand. Ossification takes place in the range of CRL 90 to 125 mm (14-16 weeks gestation). Ossification sequence of the phalanx in DS fetuses is normal but all the ossification process is abnormal with MPFD even more delayed, abnormal in shape, or absent. 18 If we look at the following Table 1 with prenatal studies regarding the association of absence of the MPFD, the incidence varies between 15.4%, 19 18.1% 20 and up to 25%. 21 Thus, hypoplasia of the middle phalanx of the fifth finger as well as reduced ratio of the middle phalanges of the fifth to the fourth digit were described among the sonographic features in fetuses with DS. However, these studies were Figs 1A and B) .
The second case, 31 years old woman at her 14 weeks, presented with severe edema, mediastinal cystic hygroma (Fig. 2) , echogenic cardiac foci (ECF), chorioamniotic separation and short long bones but with normal nuchal fold.
The next case (no. 3), 14+3 weeks in a 32 years old woman, presented with metopic wormian bone, short long bones, hypoplastic nasal bone, ECF (Fig. 3) , absent MPFD and normal NT. Chaoui et al 23 have described abnormal metopic suture using three-dimensional ultrasound with maximal mode rendering. They have found four types of abnormality in the metopic suture, i.e. delayed development (V or Y-shape), U-shaped, premature closure and the presence of additional bone. Wormian bone derives from the 1,643 description of the sutural bones by Olas Worm to Thomas Bartholin. Early in the 16th century the first association between wormian bones and cerebral disorders was recognized. The incidence is not quite known and supposed to be around 11.3% in fetuses, higher in the normal adult population (8-15%) and up to 54% in mentally disabled. There is no difference between sexes and the commonest suture to arise is the Lambdoid suture (50%), followed by the coronal suture (25%). 24 In a recent study, 25 there was a high proportion (53%) of wormian bones in the general pediatric population and in their study wormian bones in the lambdoid suture were also found by far the greatest numbers. While searching the literature, we have found only numerous cases of wormian bone associated with chromosomal abnormalities. Mainly, there are some reports of skeletal dysplasia associated with various chromosomal abnormalities. The dysplasias include cleidocranial dysplasia associated with de novo balanced translocation, 26, 27 pathogenic gene mutation, 28 mutations in the RUNX2 gene 29 and abnormalities of 8q22. 30 Osteogenesis imperfecta is also associated with mutations in COL1A1/2 31,32 as well as other rare skeletal dysplasias. Another report of the association of wormian bones and chromosomal abnormalities is Lhermitte-Duclos disease arising in the paternal chromosome and presented with polydactyly and wormian bone. 33 In Faro's study, 34 the development of the frontal bones and metopic suture in trisomy 21 is as normal and independent from the development of the nasal bones. So, our case with metopic wormian bone is the first association between wormian bone and trisomy 21. The next case (no. 4), aged 36 in her 15+5 gestational week, presented with the 'classical' sighs for DS. It had atrioventricular (AV) septal defect (AV canal), increased nuchal fold, ECF, hypoplastic nasal bone, echogenic bowel (Fig. 4) and absent MPFD. AV canal is a common AV junction with a five-leaflet common valve. The incidence is 3 to 7% of congenital heart defects in infants and in fetuses the incidence is higher: 11 to 17%. It has three types (A-C) according to Rastellis classification. Regarding prenatal diagnosis, the normal: AV valves have a differential insertion on the septum. The tricuspid valve is slightly more apically inserted. The view of the AV valves with the septum and septum primum provide an image with resembles a cross-the crux of the heart. The sonographic appearance of AV canal include a large hole in the middle of the heart and the absence of the crux, linear insertion (nondifferential insertion) of the AV valves, common AV junction and VSD or absence of septum primum. A total of 66% of fetuses with AV septal defect have DS and 25% of fetuses with DS have AVD. [35] [36] [37] The fifth case has no structural abnormality-only vascular aberrations. The woman, aged 32 in her 15+1 gestational week, presented with aberrant right subclavian artery (ARSA) (Fig. 5) , umbilical vein (UV) anomaly along with ECF. ARSA was proposed as a new sonographic findings as a marker tool for the detection of high risk fetuses for DS, first by Chaoui et al 38 and later by us. 39 Both groups had similar results-in DS fetuses the incidence of ARSA was 37.5%, in comparison to normal fetuses-1.4%, making the LR = 25 (Chaoui) and odds ratio (OR) of 42 (in our study). In our study, in all our DS cases it was found in combination with other sonographic markers and/or abnormalities, such as persistent left SVC (PLSVC), cystic hygroma with tricuspid regurgitation and ECF, bilateral CPC, hyperechogenic bowel with polyhydramnios and VSD. Achiron et al 40 have found that in 11% the UV was connected to the hepatic portion of the inferior vena cava (IVC) at a position lower than its usual site while only 0.12% fetuses with normal karyotype demonstrated similar anomalous insertion of the UV into the IVC, making the OR for abnormal umbilicoportal venous system in fetuses with DS compared with the normal population of 107.4. Our case had also the same UV anomaly. We have to remember that DS cases do not always present with structural abnormalities. We have a case of a woman that we have followed in three pregnancies-the first one presented with ARSA as an isolated finding. The karyotype revealed de novo translocation and she terminated the pregnancy. In the second pregnancy the anomaly scan revealed double aortic arch-the karyotype was normal. In the third pregnancy, while she was 35 years old she had a
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normal NT scan at 12 weeks and anomaly scan at 15 weeks. The triple test had a 1:80 risk for DS and the karyotype was indeed DS.
CONCLUSION
We have shown herein the various presentations of DS cases. We have described five different cases of DS, having each a unique sonographic abnormality and reviewed the literature dealing with these findings. The meta-analysis done by Smith-Bindman 41 searching 56 articles (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) describing 1930 DS fetuses and 130,365 normal fetuses. This meta-analysis revealed that when observed without associated structural anomalies, ultrasonographic markers could not discriminate well between unaffected fetuses and DS fetuses. Using these markers as a basis of deciding to offer amniocentesis will result in more fetal losses than DS detected and will lead to decrease in the prenatal detection of DS. Therefore, the use of the genetic sonogram, especially in early pregnancy, based mainly on structural anomalies, will lessen the false-positive DS detection and hence, the anxiety of the patients or terminating the pregnancy when necessary.
